Medicare Launches Weight Loss Drug Coverage Pilot Program Starting July 1

Want the full story?
Read the complete article at KVIA
AI Summary
Starting July 1, millions of Medicare recipients will gain access to weight loss medications through a new pilot program called 'Medicare GLP-1 Bridge.' This initiative aims to provide affordable options for seniors struggling with obesity, allowing eligible participants to access drugs like Wegovy and Zepbound for as low as $50 per month. The program targets individuals with a BMI of 35 or higher, or those with a BMI of 30-35 who have specific health conditions. This marks a significant shift in Medicare policy, as obesity treatment has long been excluded from coverage. Many seniors, like Mary Abrahamson, are hopeful that this program will improve their quality of life and reduce financial burdens associated with weight loss medications.
Key Details: • Program begins on July 1, 2023. • Eligible participants must meet specific health criteria related to BMI and existing health conditions. • Monthly costs for medications could drop to $50 from over $400. • Participants need to request a prescription from their doctor and complete a prior authorization form.